Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Paroxewave 12.5mg Tablet CR

Prescription Icon
Prescription Required

Marketer

Axonwave Pharmaceuticals Private Limited

Salt Composition

Paroxetine (12.5mg)

Overview Paroxewave 12.5mg Tablet CR

Sertraline CR 12.5mg tablets are antidepressants classified as selective serotonin reuptake inhibitors (SSRIs). Prescribed extensively for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, these tablets help many individuals recover by alleviating symptoms of low mood, anxiety, and tension. Administration is independent of food intake; dosage and frequency are determined by your physician to effectively manage your symptoms. Your doctor might initiate treatment with a lower dose, gradually increasing it as needed. Never alter your dosage or discontinue use without consulting your doctor; abrupt cessation can worsen your condition or trigger withdrawal (including anxiety, agitation, rapid heartbeat, dizziness, sleep problems, etc.). For optimal results, take the medication consistently at the same time daily—morning administration may be recommended if sleep is affected. Significant improvement may take several weeks. Report any lack of progress after four weeks. Common side effects encompass nausea, tiredness, dry mouth, appetite changes, increased perspiration, lightheadedness, nervousness, shaking, sleep difficulties, and constipation. Reduced libido, delayed ejaculation, and impotence are also potential sexual side effects. Report immediately any sudden mood deterioration or suicidal thoughts. Prior to commencing treatment, inform your doctor of any epilepsy, diabetes, liver or kidney impairment, heart conditions, or glaucoma as these may influence treatment. Consult your physician before use if pregnant or breastfeeding. Interactions are possible with certain medications, particularly other antidepressants and MAO inhibitors; provide your doctor with a complete list of all your medications to ensure safety.

Uses of Paroxewave 12.5mg Tablet CR

Managing depressive symptoms | Addressing panic attacks and panic disorder | Anxiety disorder intervention and care

Major Benefits of Paroxewave 12.5mg Tablet CR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Paroxewave 12.5mg Controlled-Release tablet can be administered with or without food, although consistent timing is recommended.

Common Side effects of Paroxewave 12.5mg Tablet CR:

  • Nausea
  • Fatigue
  • Dryness in mouth
  • Loss of appetite
  • Increased sweating
  • Dizziness
  • Nervousness
  • Tremors
  • Low sexual desire
  • Insomnia (difficulty in sleeping)
  • Confusion
  • Constipation
  • Erectile dysfunction
  • Delayed ejaculation
  • Decreased libido

How to use Paroxewave 12.5mg Tablet CR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Paroxewave 12.5mg Tablet CR whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—choose a specific time each day.

How Paroxewave 12.5mg Tablet CR works:

Serotonin levels in the brain are boosted by the extended-release Paroxewave 12.5mg tablet, a selective serotonin reuptake inhibitor (SSRI) used to treat depression. This mechanism alleviates depressive symptoms, both emotional and physical, and offers relief from panic disorder, anxiety, and obsessive-compulsive disorder.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Paroxewave 12.5mg Tablet CR is inadvisable.

PregnancyPregnancyUNSAFE

The extended-release Paroxewave 12.5mg tablet is contraindicated in pregnancy. Preclinical and clinical studies reveal substantial risks to fetal development, mandating consultation with a physician before use during gestation.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Paroxetine 12.5mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Extended-release Paroxewave 12.5mg tablets can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Paroxewave 12.5mg controlled-release tablets cautiously. Dosage modification of Paroxewave 12.5mg controlled-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Paroxewave 12.5mg Controlled-Release tablets. Dosage modification of Paroxewave 12.5mg Controlled-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Paroxewave 12.5mg Tablet CR :

Should you forget to take a Paroxewave 12.5mg Controlled-Release tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Paroxewave 12.5mg Tablet CR

LabelValue
Type of Compound Piperidine-based phenyl derivative
Potential for Dependence None.
Treatment Category Central and Peripheral Nervous System
Mechanism of Action Serotonin-specific reuptake inhibitors

FAQs on Paroxewave 12.5mg Tablet CR

Noticeable symptom relief may begin within one to two weeks of commencing treatment. However, if you experience no improvement, continue taking the medication and schedule an appointment with your physician. Complete therapeutic effects may take four to six weeks to become apparent.
Discontinuing Paroxewave 12.5mg Tablet CR suddenly, without medical advice, is strongly discouraged. While an initial increase in symptoms is possible with this medication, therapeutic effects typically become evident within one to two weeks. However, if symptom exacerbation persists beyond this timeframe, a physician should be consulted immediately.
Sexual function may be impacted by the use of Paroxewave 12.5mg CR tablets. Reduced libido and difficulties achieving orgasm can occur in both genders. Furthermore, males might experience erectile dysfunction and ejaculatory problems.
Paroxewave 12.5mg Controlled-Release tablets are contraindicated for individuals younger than 18. This age group exhibits a heightened susceptibility to adverse reactions, including suicidal ideation, hostility, defiant conduct, and irritability, upon administration of Paroxewave 12.5mg CR tablets. Should your child be prescribed this medication and concerns arise regarding these potential side effects, a consultation with their physician is recommended.
Concurrent use of Paroxewave 12.5mg Tablet CR and tamoxifen is not recommended. While Paroxewave 12.5mg Tablet CR might alleviate tamoxifen-induced hot flashes, its administration alongside tamoxifen diminishes tamoxifen's efficacy and may increase the risk of breast cancer reappearance.
Diabetic patients should exercise caution when using Paroxewave 12.5mg Tablet CR. This medication can influence blood glucose, potentially requiring adjustments to insulin or other diabetes treatments. Consult your physician for guidance and monitor your blood sugar regularly.
Paroxewave 12.5mg Tablet ...
113
MRP 138
18% off